ChartMill assigns a Buy % Consensus number of 86% to AAPG. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-10 | BTIG | Initiate | Buy |
| 2025-11-05 | Piper Sandler | Initiate | Overweight |
| 2025-03-27 | JP Morgan | Initiate | Overweight |
13 analysts have analysed AAPG and the average price target is 39.73 USD. This implies a price increase of 30.98% is expected in the next year compared to the current price of 30.33.
The consensus rating for ASCENTAGE PHARMA GR-ADR (AAPG) is 86.1538 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ASCENTAGE PHARMA GR-ADR (AAPG) is 13.